Localized Optogenetic Targeting of Rotors in Atrial Cardiomyocyte Monolayers

Background: Recently, a new ablation strategy for atrial fibrillation has emerged, which involves the identification of rotors (ie, local drivers) followed by the localized targeting of their core region by ablation. However, this concept has been subject to debate because the mode of arrhythmia termination remains poorly understood, as dedicated models and research tools are lacking. We took a unique optogenetic approach to induce and locally target a rotor in atrial monolayers. Methods and Results: Neonatal rat atrial cardiomyocyte monolayers expressing a depolarizing light-gated ion channel (Ca2+-translocating channelrhodopsin) were subjected to patterned illumination to induce single, stable, and centralized rotors by optical S1-S2 cross-field stimulation. Next, the core region of these rotors was specifically and precisely targeted by light to induce local conduction blocks of circular or linear shapes. Conduction blocks crossing the core region, but not reaching any unexcitable boundary, did not lead to termination. Instead, electric waves started to propagate along the circumference of block, thereby maintaining reentrant activity, although of lower frequency. If, however, core-spanning lines of block reached at least 1 unexcitable boundary, reentrant activity was consistently terminated by wave collision. Lines of block away from the core region resulted merely in rotor destabilization (ie, drifting). Conclusions: Localized optogenetic targeting of rotors in atrial monolayers could lead to both stabilization and destabilization of reentrant activity. For termination, however, a line of block is required reaching from the core region to at least 1 unexcitable boundary. These findings may improve our understanding of the mechanisms involved in rotor-guided ablation.

[1]  J. Bates,et al.  Prospective, Tissue-Specific Optimization of Ablation for Multiwavelet Reentry: Predicting the Required Amount, Location, and Configuration of Lesions , 2016, Circulation. Arrhythmia and electrophysiology.

[2]  D. Ypey,et al.  Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. , 2014, Cardiovascular research.

[3]  Aristides B. Arrenberg,et al.  Optogenetic Control of Cardiac Function , 2010, Science.

[4]  José Jalife,et al.  Rotors and the Dynamics of Cardiac Fibrillation , 2013, Circulation research.

[5]  J. Bates,et al.  Ablation of multi-wavelet re-entry: general principles and in silico analyses. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  Francesco S. Pavone,et al.  Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation , 2016, Scientific Reports.

[7]  I. Feola,et al.  Optogenetic Engineering of Atrial Cardiomyocytes. , 2016, Methods in molecular biology.

[8]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[9]  L. Gepstein,et al.  Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. , 2014, Cardiovascular research.

[10]  Alexander V Panfilov,et al.  Small size ionic heterogeneities in the human heart can attract rotors. , 2014, American journal of physiology. Heart and circulatory physiology.

[11]  Udi Nussinovitch,et al.  Optogenetics for in vivo cardiac pacing and resynchronization therapies , 2015, Nature Biotechnology.

[12]  Andrés Orozco-Duque,et al.  Effect of the electrograms density in detecting and ablating the tip of the rotor during chronic atrial fibrillation: an in silico study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  D. Atsma,et al.  Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. , 2011, Cardiovascular research.

[14]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[15]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[16]  M. Schalij,et al.  Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management , 2016, European heart journal.

[17]  D. Ypey,et al.  Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block , 2017, Cardiovascular research.

[18]  Hugh Calkins,et al.  Catheter ablation in patients with persistent atrial fibrillation , 2016, European heart journal.

[19]  O. Alfieri,et al.  Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation , 2001, Circulation.

[20]  D. Haines,et al.  Cellular Electrophysiological Effects of Hyperthermia on Isolated Guinea Pig Papillary Muscle Implications for Catheter Ablation , 1993, Circulation.

[21]  Wouter-Jan Rappel,et al.  Mechanisms for the Termination of Atrial Fibrillation by Localized Ablation: Computational and Clinical Studies , 2015, Circulation. Arrhythmia and electrophysiology.

[22]  Thomas V. Karathanos,et al.  Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. , 2016, The Journal of clinical investigation.

[23]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[24]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[25]  Lluís Mont,et al.  Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.

[26]  Roland N. Emokpae,et al.  Spiral Wave Attachment to Millimeter-Sized Obstacles , 2006, Circulation.

[27]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[28]  T. Bruegmann,et al.  Optogenetic control of heart muscle in vitro and in vivo , 2010, Nature Methods.